Arrowhead Pharmaceuticals Valuation
| 0HI3 Stock | 18.58 0.05 0.27% |
At this time, the firm appears to be overvalued. Arrowhead Pharmaceuticals shows a prevailing Real Value of USD15.61 per share. The current price of the firm is USD18.58. Our model approximates the value of Arrowhead Pharmaceuticals from analyzing the firm fundamentals such as Shares Outstanding of 88.02 M, return on equity of -1.52, and Operating Margin of (27.85) % as well as examining its technical indicators and probability of bankruptcy.
Enterprise Value 2.3 B | Price Sales 91.9702 |
Overvalued
Today
Please note that Arrowhead Pharmaceuticals' price fluctuation is not too volatile at this time. Calculation of the real value of Arrowhead Pharmaceuticals is based on 3 months time horizon. Increasing Arrowhead Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Arrowhead stock is determined by what a typical buyer is willing to pay for full or partial control of Arrowhead Pharmaceuticals Corp. Since Arrowhead Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Arrowhead Stock. However, Arrowhead Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 18.58 | Real 15.61 | Hype 18.57 | Naive 17.21 |
The intrinsic value of Arrowhead Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Arrowhead Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Arrowhead Pharmaceuticals Corp helps investors to forecast how Arrowhead stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Arrowhead Pharmaceuticals more accurately as focusing exclusively on Arrowhead Pharmaceuticals' fundamentals will not take into account other important factors: Arrowhead Pharmaceuticals Cash |
|
Arrowhead Pharmaceuticals Total Value Analysis
Arrowhead Pharmaceuticals Corp is presently projected to have takeover price of 2.32 B with market capitalization of 180.7 B, debt of 115.17 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Arrowhead Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.32 B | 180.7 B | 115.17 M |
Arrowhead Pharmaceuticals Investor Information
About 80.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 1.08. Arrowhead Pharmaceuticals had not issued any dividends in recent years. Based on the key indicators related to Arrowhead Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Arrowhead Pharmaceuticals Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Arrowhead Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Arrowhead Pharmaceuticals has an asset utilization ratio of 31.45 percent. This implies that the Company is making USD0.31 for each dollar of assets. An increasing asset utilization means that Arrowhead Pharmaceuticals Corp is more efficient with each dollar of assets it utilizes for everyday operations.Arrowhead Pharmaceuticals Ownership Allocation
Arrowhead Pharmaceuticals holds a total of 88.02 Million outstanding shares. The majority of Arrowhead Pharmaceuticals Corp outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Arrowhead Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Arrowhead Pharmaceuticals. Please pay attention to any change in the institutional holdings of Arrowhead Pharmaceuticals Corp as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Arrowhead Pharmaceuticals Profitability Analysis
The company reported the revenue of 240.74 M. Net Loss for the year was (209.28 M) with profit before overhead, payroll, taxes, and interest of 240.74 M.About Arrowhead Pharmaceuticals Valuation
The stock valuation mechanism determines Arrowhead Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Arrowhead Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Arrowhead Pharmaceuticals. We calculate exposure to Arrowhead Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Arrowhead Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 276.8 M | 290.7 M |
Additional Tools for Arrowhead Stock Analysis
When running Arrowhead Pharmaceuticals' price analysis, check to measure Arrowhead Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arrowhead Pharmaceuticals is operating at the current time. Most of Arrowhead Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Arrowhead Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arrowhead Pharmaceuticals' price. Additionally, you may evaluate how the addition of Arrowhead Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.